These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1827016)

  • 1. Beneficial effects of the calcium antagonist isradipine on apolipoproteins in hypertensive patients.
    Lacourcière Y; Gagné C; Brun D; Poirier L; Dion D; Yardley C
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):181S-184S. PubMed ID: 1827016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension.
    Samuel P; Kirkendall W; Schaefer EJ; Chin B; Schoenfeld BH; Gonasun LM; Lieberman S
    Am J Cardiol; 1988 Nov; 62(16):1068-71. PubMed ID: 2973219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension.
    Samuel P
    Cor Vasa; 1990; 32(2 Suppl 1):35-41. PubMed ID: 2143459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.
    Fetkovská N; Fedelesová V; Kozlovský M; Dzúrik R
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):175S-177S. PubMed ID: 1827014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
    Welzel D; Burger KJ
    Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
    Nelson EB; Pool JL; Taylor AA
    Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of isradipine on factors affecting blood viscosity.
    Slonim A; Paran E; Cristal N
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):172S-174S. PubMed ID: 1827013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
    Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
    J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term lipid profiles with isradipine and hydrochlorothiazide treatment in elderly hypertensive patients.
    Stein GH; Matthews K; Bannatyne RE; Quay G; Lopez L; McCarley D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S90-2. PubMed ID: 1695313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of isradipine and atenolol on lung function in patients with mild essential hypertension.
    Reiterer W; Meisner W
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):197S-199S. PubMed ID: 1827021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects of the calcium antagonist isradipine, a double-blind placebo-controlled study.
    Kühlkamp V; Maier F; Seipel L
    Int J Cardiol; 1991 Feb; 30(2):215-20. PubMed ID: 1826285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the calcium antagonist isradipine in angina pectoris.
    Parker JO; Enjalbert M; Bernstein V
    Cardiovasc Drugs Ther; 1988 Mar; 1(6):661-4. PubMed ID: 2978997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension.
    Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
    Persson B; Wysocki M; Andersson OK
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effect of isradipine in pindolol-treated patients.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1987 Dec; 5(5):S567-70. PubMed ID: 2965231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.